Cartesian Therapeutics
Gaithersburg
About Cartesian Therapeutics
Cartesian Therapeutics is a fully integrated, clinical-stage biopharmaceutical company developing novel cell and gene immunotherapies to treat cancer and autoimmune diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $132.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2024)
- Ticker: nasdaq:RNAC
- Website: cartesiantherapeutics.com
Industries & Categories
Biotechnology, Oncology
Social Profiles
Canonical: https://fsome.com/organization/cartesian-therapeutics-58245 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.